eHealthMe - FDA and Social Media, Personalized eHealthMe - a cloud computing service for drugs

FDA and Social Media, Personalized

Advanced tools
Browse all drugs       All conditions, symptoms, side effects

From FDA reports: drug interactions between Urso 250, Omeprazole, Norvasc, Losartan Potassium, Levofloxacin for a Female patient aged 82

This is a personalized study for a 82 year old female patient. The study is created by eHealthMe based on reports of 2 people who take the same drugs and have drug interactionsfrom FDA.

Get a free personalized report of your drugs: we study for you 352 million drug outcomes from FDA and social media. Start to use eHealthMe >>>

On Aug, 25, 2014: 2 people who reported to have interactions when taking Urso 250, Omeprazole, Norvasc, Losartan Potassium, Levofloxacin are studied

Trend of Urso 250, Omeprazole, Norvasc, Losartan Potassium, Levofloxacin's drug interactions, side effects, and effectiveness reports (114527)

Information of the patient in this study:

Age: 82

Gender: female

Conditions: Biliary Cirrhosis

Drugs taking:
- Urso 250
- Omeprazole
- Norvasc
- Losartan Potassium
- Levofloxacin

Drug interactions have: Disease Progression, Haemorrhoidal Haemorrhage, Hepatic Lesion, Iron Deficiency Anaemia, Oesophageal Varices Haemorrhage, Reflux Oesophagitis, Renal Disorder

eHealthMe real world results:

Comparison with this patient's adverse outcomes among females aged 82 (±5):

InteractionNumber of reports
Disease Progression2 (100.00%)
Haemorrhoidal Haemorrhage (bleeding from the haemorrhoids)2 (100.00%)
Hepatic Lesion2 (100.00%)
Iron Deficiency Anaemia2 (100.00%)
Oesophageal Varices Haemorrhage (bleeding from extremely dilated sub-mucosal veins in the lower third of the oesophagus)2 (100.00%)
Reflux Oesophagitis (an oesophageal mucosal injury that occurs of gastric contents into the oesophagus)2 (100.00%)
Renal Disorder (kidney disease)2 (100.00%)

Most common interactions experienced by females aged 82 (±5) in the use of Urso 250, Omeprazole, Norvasc, Losartan Potassium, Levofloxacin:

InteractionNumber of reports
Iron Deficiency Anaemia2
Dyspnoea (difficult or laboured respiration)2
Epistaxis (bleed from the nose)2
Disease Progression2
Haemorrhoidal Haemorrhage (bleeding from the haemorrhoids)2
Renal Disorder (kidney disease)2
Oesophageal Varices Haemorrhage (bleeding from extremely dilated sub-mucosal veins in the lower third of the oesophagus)2
Reflux Oesophagitis (an oesophageal mucosal injury that occurs of gastric contents into the oesophagus)2
Hepatic Lesion2

Most common interactions experienced by females aged 82 (±5) in long term use of Urso 250, Omeprazole, Norvasc, Losartan Potassium, Levofloxacin:

None.

For people in general (regardless of gender or age):

Comparison with this patient's adverse outcomes:

InteractionNumber of reports
Disease Progression2 (100.00%)
Haemorrhoidal Haemorrhage (bleeding from the haemorrhoids)2 (100.00%)
Hepatic Lesion2 (100.00%)
Iron Deficiency Anaemia2 (100.00%)
Oesophageal Varices Haemorrhage (bleeding from extremely dilated sub-mucosal veins in the lower third of the oesophagus)2 (100.00%)
Reflux Oesophagitis (an oesophageal mucosal injury that occurs of gastric contents into the oesophagus)2 (100.00%)
Renal Disorder (kidney disease)2 (100.00%)

Most common interactions experienced by people in the use of Urso 250, Omeprazole, Norvasc, Losartan Potassium, Levofloxacin:

InteractionNumber of reports
Iron Deficiency Anaemia2
Dyspnoea (difficult or laboured respiration)2
Epistaxis (bleed from the nose)2
Disease Progression2
Haemorrhoidal Haemorrhage (bleeding from the haemorrhoids)2
Renal Disorder (kidney disease)2
Oesophageal Varices Haemorrhage (bleeding from extremely dilated sub-mucosal veins in the lower third of the oesophagus)2
Reflux Oesophagitis (an oesophageal mucosal injury that occurs of gastric contents into the oesophagus)2
Hepatic Lesion2

Most common interactions experienced by people in long term use of Urso 250, Omeprazole, Norvasc, Losartan Potassium, Levofloxacin:

None.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

You can also:

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

   

All drugs: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
All conditions: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

About - Terms of service - Privacy policy - Press - Advertise - Apps - Testimonials - Contact us

 
© 2014 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.